2022 annual financial data
Xeris Biopharma Holdings 2022 Net income growth
Direct answer
Net income growth was 22.87%.
Operating income was -81,940,000 USD and net income was -94,660,000 USD.
Operating cash flow was -102,891,000 USD.
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 110,248,000 USD
- Operating income
- -81,940,000 USD
- Net income
- -94,660,000 USD
- Operating cash flow
- -102,891,000 USD